The purpose of the CMD is to give an update of Elekta’s strategy to provide the best cancer care for patients worldwide. Topics to be covered are innovations, including software, improving our customers’ clinical workflows through services and partnerships, as well as driving adoption of the latest technology across the globe. Speakers at the event will include Gustaf Salford, President and CEO as well as other leaders of Elekta.
 
The CMD will be broadcast live online and we also welcome institutional investors and financial analysts to attend in person at Elekta’s office in Crawley, UK. The webcast will start at 09:45 BST and end at 12:15 BST, including a Q&A session. For those attending in person, there will then be lunch together with members of the Executive Management team followed by the opportunity to get a closer look at Elekta’s product portfolio. A recording of the CMD will be published on Elekta’s website after the event.
 
To attend (online or in person) and for more information, please register through the following link no later than June 4, 2023: https://events.elekta.com/elekta-s-capital-markets-day
 
# # #
 
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CEST (Central European Summer Time)
 
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.